Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa

Zikhethele - 为您选择:评估对南非治疗中断后返回艾滋病毒护理的患者的基于选择的抗逆转录病毒治疗支持

基本信息

  • 批准号:
    10612080
  • 负责人:
  • 金额:
    $ 10.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-23 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY People living with HIV (PLH) are likely to cycle into and out of antiretroviral therapy (ART) services over time. Even after return to HIV care (RTC), PLH who have interrupted treatment remain vulnerable to attrition and poor treatment outcomes. A range of evidence-based ART support interventions exist including community- based and mobile health (mHealth) ART support interventions. The overarching goals of this proposal are to understand existing RTC practices, incorporate patient preference to refine a community-based and mHealth ART support intervention, and examine the role of choice in delivering RTC ART support. Candidate: Dr. Phillips is an HIV epidemiologist with training in quantitative research methods and experience with field research implementation in South Africa. She is applying for a five-year Fogarty Emerging Global Leader Award to obtain the additional training, mentorship and experience required to become a leading independent investigator capable of obtaining R-series funding. Mentoring: She has assembled an exceptional multidisciplinary team with extensive expertise in HIV intervention research in sub-Saharan Africa (SSA). Drs. Myer (University of Cape Town (UCT)) and Chi (University of North Carolina (UNC)) will serve as primary mentors providing complementary expertise on HIV intervention research and implementation science. Drs Maman (UNC) and Knight (UCT), co-mentors, are social scientists with expertise in qualitative and behavioral research particularly in the context of intervention design and evaluation. Dr. Thirumurthy (University of Pennsylvania: expertise in behavioral economics and measuring patient preference), Dr. Bekker (UCT: expertise in HIV care interventions and preference trials for contraceptive and HIV prevention methods), Dr. Hosseinipour (UNC: expertise in clinical, health service and implementation science with long-term adult HIV care in SSA) and Dr. Clouse (Vanderbilt University: expertise in mHealth intervention research in South Africa) will provide scientific advice in these areas. Training: Specific training in intervention design and evaluation – specifically incorporating implementation science, social and behavioral methods, and patient preference – will be achieved through intensive mentored training and formal coursework. This, combined with the experience gained through implementing my research aims, will establish Dr. Phillips’ independent research career investigating interventions to support lifelong HIV care. Research: The specific aims of this research are to: 1) characterize existing practices for providing RTC ART support and patient experience following RTC, 2) refine existing community-based and mHealth ART support interventions based on RTC patient preferences for modifiable attributes, and 3) determine the feasibility, acceptability and preliminary impact of offering a choice of ART support intervention to RTC patients. The results of this study will inform our understanding of RTC ART support including the role of patient choice. They will provide preliminary data needed to apply for an R01 to conduct a patient preference trial to rigorously examine the impact of patient choice in ART support delivery.
项目概要 随着时间的推移,艾滋病毒感染者 (PLH) 可能会循环使用和退出抗逆转录病毒治疗 (ART) 服务。 即使在返回艾滋病毒护理 (RTC) 后,中断治疗的 PLH 仍然容易受到人员流失和影响 治疗效果不佳。存在一系列基于证据的 ART 支持干预措施,包括社区- 基于移动医疗 (mHealth) 的 ART 支持干预措施。该提案的总体目标是 了解现有的 RTC 实践,结合患者偏好来完善基于社区的移动医疗 ART 支持干预,并检查选择在提供 RTC ART 支持中的作用。候选人:Dr. 菲利普斯是一位艾滋病毒流行病学家,接受过定量研究方法方面的培训并具有现场经验 南非的研究实施。她正在申请为期五年的福格蒂新兴全球领导者职位 获得成为领先独立人士所需的额外培训、指导和经验的奖励 能够获得 R 系列资助的研究者。指导:她组建了一支杰出的 多学科团队在撒哈拉以南非洲 (SSA) 的艾滋病毒干预研究方面拥有丰富的专业知识。博士。 Myer(开普敦大学 (UCT))和 Chi(北卡罗来纳大学 (UNC))将作为主要学生 导师提供艾滋病毒干预研究和实施科学方面的补充专业知识。博士 Maman (UNC) 和 Knight (UCT) 是共同导师,他们是在定性和行为方面具有专业知识的社会科学家 特别是在干预设计和评估方面的研究。 Thirumurthy 博士(University of 宾夕法尼亚州:行为经济学和测量患者偏好方面的专业知识),Bekker 博士(UCT: 艾滋病毒护理干预措施以及避孕和艾滋病毒预防方法偏好试验方面的专业知识),博士。 Hosseinipour(UNC:长期成人艾滋病毒临床、卫生服务和实施科学方面的专业知识 SSA 的护理)和 Clouse 博士(范德比尔特大学:南非移动医疗干预研究的专业知识) 将在这些领域提供科学建议。培训:干预设计和评估方面的具体培训 – 特别结合实施科学、社会和行为方法以及患者偏好——将 通过强化指导培训和正式课程来实现。这个结合经验 通过实现我的研究目标而获得的成果,将建立菲利普斯博士的独立研究生涯 调查支持终身艾滋病毒护理的干预措施。研究:本研究的具体目的是:1) 描述在 RTC 之后提供 RTC ART 支持和患者体验的现有实践,2) 完善 基于 RTC 患者偏好的现有社区和 mHealth ART 支持干预措施 可修改的属性,3) 确定提供选择的可行性、可接受性和初步影响 对 RTC 患者的 ART 支持干预。这项研究的结果将有助于我们了解 RTC ART 支持包括患者选择的作用。他们将提供申请 R01 所需的初步数据 进行患者偏好试验,严格检查患者选择对 ART 支持提供的影响。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Smartphone Ownership and Usage Among Pregnant Women Living With HIV in South Africa: Secondary Analysis of CareConekta Trial Data.
智能手机的所有权和南非艾滋病毒孕妇的使用:Careconekta试验数据的次要分析。
  • DOI:
    10.2196/43855
  • 发表时间:
    2023-06-22
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Noholoza, Sandisiwe;Phillips, Tamsin K.;Madwayi, Sindiswa;Mrubata, Megan;Camlin, Carol S.;Myer, Landon;Clouse, Kate
  • 通讯作者:
    Clouse, Kate
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tamsin Kate Phillips其他文献

Tamsin Kate Phillips的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tamsin Kate Phillips', 18)}}的其他基金

Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa
Zikhethele - 为您选择:评估对南非治疗中断后返回艾滋病毒护理的患者的基于选择的抗逆转录病毒治疗支持
  • 批准号:
    10472733
  • 财政年份:
    2021
  • 资助金额:
    $ 10.06万
  • 项目类别:
Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa
Zikhethele - 为您选择:评估对南非治疗中断后返回艾滋病毒护理的患者的基于选择的抗逆转录病毒治疗支持
  • 批准号:
    10295062
  • 财政年份:
    2021
  • 资助金额:
    $ 10.06万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 10.06万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 10.06万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 10.06万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 10.06万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 10.06万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 10.06万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 10.06万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 10.06万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 10.06万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 10.06万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了